JacobsenSLauszusFFJeppesenCK, et al.Vaginal laser therapy for urogenital symptoms in postmenopausal women and breast cancer survivors. Danish Obstetrics Gynaecology2023; 2(1): 15–21.
2.
SiliquiniGPBounousVENovaraL, et al.Fractional CO2 vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors. Breast J2021; 27(5): 448–455.
3.
LiFGMaheux-LacroixSDeansR, et al.Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA, J Am Med Assoc2021; 326(14): 1381–1389.
4.
AdelmanMNygaardIE. Time for a ‘Pause’ on the Use of vaginal laser. JAMA, J Am Med Assoc2021; 326(14): 1378–1380.
5.
VeronLWehrerDAnnerose-ZéphirG, et al.Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. Breast Cancer Res Treat2021; 188(2): 501–509.
6.
JhaSWyldLKrishnaswamyPH. The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis. Clin Breast Cancer2019; 19(4): e556–e562, PubMed PMID: 31227415.
